|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 5/071 | (2010.01) |
| A61L 27/36 | (2006.01) | ||
| A61L 27/38 | (2006.01) | ||
| A61L 27/54 | (2006.01) | ||
| A61K 35/54 | (2015.01) |
| (11) | Number of the document | 2602316 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13157678.7 |
| Date of filing the European patent application | 2008-08-29 | |
| (97) | Date of publication of the European application | 2013-06-12 |
| (45) | Date of publication and mention of the grant of the patent | 2016-09-21 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 935767 P | 2007-08-30 | US | |
| 07115352 | 2007-08-30 | EP |
| (72) |
Bechor, Edna, IL
Bar, Liliana, IL
Nur, Israel, IL
|
| (73) |
Omrix Biopharmaceuticals Ltd.,
Weizmann Scientific Park Bldg. 14, Nes-Ziona, 76106 Rehovot,
IL
|
| (54) | Compositions suitable for treatment of spinal disease, disorder or condition |
| Compositions suitable for treatment of spinal disease, disorder or condition |